pio3-shutterstock-com-2

pio3 / Shutterstock.com (Warner-Lambert, now a part of Pfizer, pictured)

1 July 2015Big Pharma

More second medical use cases on horizon, say lawyers

After the English High Court yesterday heard the second day’s arguments in the dispute between Actavis and Warner-Lambert concerning second medical use patents, two lawyers have told LSIPR that similar cases may be on the horizon.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gene tech firm fends off injunction in test kit dispute

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve